Lenvatinib plus TACE with or without pembrolizumab for the treatment of initially unresectable hepatocellular carcinoma harbouring PD-L1 expression: a retrospective study

Song Chen(Wayne State University), Wenbo Guo(Sun Yat-sen University)
Journal of Cancer Research and Clinical Oncology
August 28, 2021
Cited by 113


Related Papers